Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
about
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and ApoptosisRegulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signallingThe function of miRNA in cardiac hypertrophyMicroRNAs regulate and provide robustness to the myogenic transcriptional networkMicroRNAs in heart failure: Small molecules with major impactNovel insights into miRNA in lung and heart inflammatory diseasesDifferential expression of microRNAs in different disease states.AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertensionmiR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathwaysIdentification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseasesmiR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activationmiR-21 improves the neurological outcome after traumatic brain injury in rats.Distinctive profile of IsomiR expression and novel microRNAs in rat heart left ventricle.Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy.Cardiac hypertrophy is negatively regulated by miR-541.MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source.Non-coding RNAs in cardiac hypertrophy.Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration.Functional effect of mir-27b on myostatin expression: a relationship in Piedmontese cattle with double-muscled phenotypeDelivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarctionSmad-mediated regulation of microRNA biosynthesis.The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension.Therapeutic manipulation of angiogenesis with miR-27bMicroRNA-27b Regulates Mitochondria Biogenesis in Myocytes.Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.1α,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the vitamin D receptor.The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancerPPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs.Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium.MicroRNAs in heart development.Puerarin Attenuates Cardiac Hypertrophy Partly Through Increasing Mir-15b/195 Expression and Suppressing Non-Canonical Transforming Growth Factor Beta (Tgfβ) Signal Pathway.MicroRNA-128 inhibition attenuates myocardial ischemia/reperfusion injury-induced cardiomyocyte apoptosis by the targeted activation of peroxisome proliferator-activated receptor gamma.MicroRNA Profiling during Craniofacial Development: Potential Roles for Mir23b and Mir133b.Negative auto-regulation of myostatin expression is mediated by Smad3 and microRNA-27.Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases.MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.
P2860
Q26746965-3F3D9896-F36C-4703-BD9E-B6E11EAB6916Q26767134-8FA51FEA-C240-4375-8B8F-E76219867C32Q26828961-E6A089D6-EB69-4FC4-8498-5C11D17BE6E4Q26992173-15BA03E7-53CE-4D31-8B9E-B725D7F7B233Q27024714-3B2602DD-5BC2-4178-96AF-9DB65398A525Q27026348-2A1989F9-9D5A-4F2E-A82A-6D35071A4F78Q27693279-57CCAD24-600C-494E-9B4F-7CB8D1F4E8FCQ28118456-5B887D0A-1FED-4FCC-BB84-8DFE7CA214F1Q28544014-1B2DFC8A-917F-4978-ADA4-58AF9C6A08B8Q28583018-097B25E1-6767-4E7C-83FA-FB925D7085B9Q28854380-EB66C22E-1A43-4B2B-890B-5BDF2DAD76EDQ30596128-630A8B9E-FFD9-4F09-8E43-270328B5EDD5Q31120462-4774C0EA-2D23-49CB-AF03-A5EABE29EC05Q31136713-EC21C49B-69AC-448C-B368-33CA19256531Q33654224-4F85B028-5D5A-4363-A19E-D2747DE7C633Q33654397-A625B255-7ABB-40A5-B733-21799F50405AQ33800147-48059F49-B575-4DE3-BCA1-D116DAB2683AQ34347568-096CC927-65B2-48A8-950F-8C7ACD05A845Q34358827-F3091F9D-EC8D-436B-9262-8987D7B04F03Q34627627-31AB9345-25D8-46FC-A3D2-24EE975D8737Q35078379-6C7DFED0-F899-4B20-BE68-0F86823613A9Q35600535-D6F0E379-3CF3-4787-828C-83A236583A7AQ35746020-41F63BA4-BE7F-45BF-A50B-17B7CB7A3831Q35835060-D668992C-79DA-4A36-8296-049606E8E122Q35915902-7E700FE8-8E88-485B-AACF-8CCC68EBDEE8Q35921700-878AA4E7-E5A2-4103-A5FC-3C53F59EBE4CQ36041636-B6D59B6B-5966-4C43-B285-2E6542BD126EQ36238973-9D999C94-3359-494A-AA79-43977C26144AQ36253614-717A3022-04B0-4E2C-BC92-A2C1B98F14BEQ36438608-941731AB-A681-4F8B-95F6-FFC1AC7AFAC1Q36710861-8312D178-99E0-4A0E-B4B3-A5CF38C090B0Q36760312-0D5E60C7-1D18-4AE0-AB9F-F31C68FA65DDQ36955783-71AA042D-2E56-4E8C-A970-3E07CD7E29CFQ37024990-AB3DE4B7-A4AC-403A-86E1-DA368218C805Q37032464-92504628-357E-4690-BD6A-BBAE5CA545F4Q37092620-AD956D5B-E21C-4EB4-9592-B7E402CDDD9BQ37538989-3A16DB42-4FA8-4600-9C6F-E0EAC620D50DQ37601935-CC39EEA3-B4C7-4A16-93E0-C2FF5962B944Q37607478-321240F6-9EE5-4206-8375-CEF5628FB236Q37699427-1D5BD4D1-58CD-4E48-AEE3-3F296F184193
P2860
Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@ast
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@en
type
label
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@ast
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@en
prefLabel
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@ast
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@en
P2093
P2860
P356
P1433
P1476
Cardiomyocyte overexpression o ...... trophy and dysfunction in mice
@en
P2093
Dawei Zhan
Lagabaiyila Zha
Shuilong Guo
Xuan Cheng
P2860
P2888
P304
P356
10.1038/CR.2011.132
P577
2011-08-16T00:00:00Z